China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (SHE:000999)
China · Delayed Price · Currency is CNY 25.28
+0.37 (1.49%)
Oct 30, 2026, 3:04 PM CST
SHE:000999 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 31,026 | 31,603 | 27,617 | 24,739 | 18,079 | 15,544 |
Revenue Growth | 3.90% | 14.43% | 11.63% | 36.84% | 16.31% | 13.98% |
Gross Profit Gross Profit Growth | 17,261 | 17,036 | 14,164 | 13,064 | 9,725 | 8,984 |
Operating Income Operating Income Growth | 4,415 | 4,430 | 4,191 | 3,543 | 2,784 | 2,214 |
Net Income Net Income Growth | 3,226 | 3,421 | 3,368 | 2,853 | 2,449 | 2,055 |
Earnings Per Share EPS Growth | 1.94 | 2.06 | 2.02 | 1.72 | 1.47 | 1.24 |
EPS Growth | 16.84% | 1.98% | 17.76% | 16.89% | 18.10% | 28.83% |
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Adjustment and Elimination Adjustment and Elimination Growth | -894.19 | -1,681 | -779.42 | -329.31 | -269.6 |
Pharmaceutical Pharmaceutical Growth | 28,330 | 24,242 | 21,449 | 17,420 | 14,883 |
Medicines, Equipment Wholesale and Retail Industry Segment Medicines, Equipment Wholesale and Retail Industry Segment Growth | 3,352 | 4,173 | 3,231 | 155.77 | 115.1 |
Printing and Packaging Printing and Packaging Growth | 814.79 | 883.42 | 838.82 | 833.38 | 815.83 |
Total Total Growth | 31,603 | 27,617 | 24,739 | 18,079 | 15,544 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 7,494 | 9,557 | 6,694 | 8,227 | 3,150 | 4,284 |
Total Debt Total Debt Growth | 3,993 | 6,423 | 1,285 | 2,998 | 385.42 | 232.18 |
Net Cash (Debt) Net Cash Growth | 3,502 | 3,134 | 5,409 | 5,229 | 2,764 | 4,052 |
Net Cash Growth | 13.49% | -42.05% | 3.45% | 89.15% | -31.78% | 1.31% |
Net Cash Per Share Net Cash Per Share Growth | 2.11 | 1.89 | 3.24 | 3.14 | 1.66 | 2.45 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 4,885 | 5,513 | 4,402 | 4,192 | 3,006 | 1,885 |
Capital Expenditures CapEx Growth | -1,398 | -1,271 | -790.07 | -857.21 | -951.57 | -872.6 |
Free Cash Flow Free Cash Flow Growth | 3,487 | 4,242 | 3,612 | 3,335 | 2,055 | 1,012 |
Free Cash Flow Growth | 11.40% | 17.43% | 8.33% | 62.28% | 103.03% | -36.83% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Gross Margin | 55.63% | 53.91% | 51.29% | 52.81% | 53.79% | 57.79% |
Operating Margin | 14.23% | 14.02% | 15.17% | 14.32% | 15.40% | 14.24% |
Pretax Margin | 14.92% | 15.39% | 16.63% | 15.18% | 16.39% | 15.72% |
Profit Margin | 10.40% | 10.82% | 12.20% | 11.53% | 13.54% | 13.22% |
FCF Margin | 11.24% | 13.42% | 13.08% | 13.48% | 11.37% | 6.51% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Dividend Per Share Dividend Per Share Growth | 1.005 | 1.040 | 1.015 | 0.887 | 0.592 | 0.505 |
Dividend Per Share Growth | 30.52% | 2.42% | 14.41% | 49.99% | 17.26% | 70.53% |
Dividend Yield | 3.98% | 3.65% | 2.98% | 3.02% | 2.14% | 2.49% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 13.03 | 13.85 | 16.91 | 17.23 | 18.89 | 16.31 |
Forward PE | 8.21 | 9.40 | 16.06 | 23.84 | 21.67 | 23.31 |
P/FCF Ratio | 12.07 | 11.17 | 15.77 | 14.74 | 22.52 | 33.12 |
PS Ratio | 1.36 | 1.50 | 2.06 | 1.99 | 2.56 | 2.16 |